Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on August 13, 2026
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
₹9,279 cr
Turnover Ratio
14.27%
Expense Ratio
0.79%
Exit Load
1.00%
if redeemed within
Returns
- 1M: Positive return: 2.47%
- 1Y: Positive return: 11.83%
- 3M: Positive return: 8.24%
- 3Y: Positive return: 19.11%
- 6M: Positive return: 14.80%
- 5Y: Positive return: 14.47%
Other plans of Nippon India Pharma